ICG-001
ICG001 is a selective small molecule inhibitor that disrupts the β-catenin/CBP interaction to block Wnt/β-catenin signaling, with an IC50 of 3 μM for CREB binding. It is a valuable research tool for studying oncogenic signaling in cancers, including colorectal carcinoma, in both cellular and animal models.
Product Specifications
CAS Number
780757-88-2
Product Name Alternative
Inhibit, EpigeneticReaderDomain, Epigenetic Reader Domain, Inhibitor, ICG 001, ICG001, ICG-001, betacatenin, beta-catenin, Beta catenin, CBP, 847591-62-2, bcatenin, Apoptosis, β-catenin, βcatenin, Wnt/β-catenin, Wnt/betacatenin, Wnt/b-catenin, Wnt
Field of Research
Cell Biology, Epigenetics & Chromatin, Signal Transduction, Stem Cell & Developmental Biology
Purity
99.55% (May vary between batches)
Solubility
2% DMSO+40% PEG300+5% Tween 80+53% Saline:10 mg/mL (18.23 mM) ; DMSO:242 mg/mL (441.1 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ; Ethanol:9 mg/mL (16.4 mM)
Smiles
Oc1ccc (C[C@@H]2N3[C@H] (CN (Cc4cccc5ccccc45) C2=O) N (CCC3=O) C (=O) NCc2ccccc2) cc1
Molecular Formula
C33H32N4O4
Molecular Weight
548.63
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
